Natixis Advisors
CNMD icon

Natixis Advisors’s CONMED CNMD Stock Holding History

Natixis Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Buy
168,502
+19,555
+13% +$704K 0.01% 888
2026
Q1 		$5.27M Buy
148,947
+41,992
+39% +$1.71M 0.01% 828
2025
Q4 		$4.34M Sell
106,955
-67,855
-39% -$2.95M 0.01% 856
2025
Q3 		$8.22M Buy
174,810
+56,876
+48% +$2.95M 0.01% 712
2025
Q2 		$6.14M Buy
117,934
+21,396
+22% +$1.17M 0.01% 778
2025
Q1 		$5.83M Sell
96,538
-26,012
-21% -$1.68M 0.01% 774
2024
Q4 		$8.39M Buy
122,550
+11,641
+10% +$811K 0.02% 703
2024
Q3 		$7.98M Buy
110,909
+29,720
+37% +$2.1M 0.02% 710
2024
Q2 		$5.63M Buy
81,189
+34,744
+75% +$2.53M 0.01% 761
2024
Q1 		$3.72M Sell
46,445
-6,136
-12% -$547K 0.01% 874
2023
Q4 		$5.76M Buy
52,581
+8,634
+20% +$893K 0.02% 713
2023
Q3 		$4.43M Buy
43,947
+5,506
+14% +$633K 0.01% 748
2023
Q2 		$5.22M Buy
38,441
+3,352
+10% +$409K 0.02% 687
2023
Q1 		$3.64M Buy
35,089
+11,084
+46% +$1.07M 0.01% 781
2022
Q4 		$2.13M Buy
24,005
+8,006
+50% +$664K 0.01% 924
2022
Q3 		$1.28M Buy
+15,999
New +$1.51M 0.01% 1028

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Natixis Advisors's CNMD Position: Q2 2026 in Review

Natixis Advisors increased its CONMED (CNMD) stake by 13% in Q2 2026, buying an estimated $704K and bringing the position to 168,502 shares worth $5.51M. The position accounts for 0.01% of the portfolio, ranked #888.

Natixis Advisors first reported a position in CNMD in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.39M in Q4 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Natixis Advisors held 168,502 shares of CONMED worth $5.51M as of Q2 2026.
  • Natixis Advisors bought 19,555 CONMED shares in Q2 2026, an estimated $704K.
  • CONMED made up 0.01% of Natixis Advisors's portfolio in Q2 2026, its #888 holding.
  • Natixis Advisors first reported a position in CONMED in Q3 2022 and has held it in 16 quarters since.
  • Natixis Advisors's CONMED position peaked at $8.39M in Q4 2024.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.